风疹活病毒载体可表达被广谱中和抗体靶向的天然HIV包膜糖蛋白并启动对包膜蛋白加强的免疫应答
研究利用风疹疫苗株RA27/3作为载体表达HIV包膜糖蛋白,在恒河猴中评估其免疫原性。载体可稳定表达来自HIV C亚型426c株、长度达363个氨基酸的Env核心糖蛋白,并绑定靶向天然CD4结合位点的广谱中和抗体。载体在恒河猴体内生长良好并全部产生疫苗「take」,单独诱导的Env抗体滴度中等,但风疹/Env初免后同源蛋白加强可产生强应答,多剂后中和抗体逐渐出现。
要点
- 风疹/Env载体可稳定表达HIV C亚型426c株Env核心糖蛋白,长度达363个氨基酸。
- 表达的Env糖蛋白可结合靶向天然CD4结合位点的广谱中和抗体。
- 载体在恒河猴体内生长良好,全部动物产生抗风疹抗体疫苗「take」。
核心结论
- 风疹/Env载体可稳定表达天然构象的HIV包膜糖蛋白,并在恒河猴中启动对同源蛋白加强的强免疫应答。
- 载体将可用于在优化载体生长和蛋白表达的条件下测试新疫苗插入片段和免疫策略。
研究设计与样本
- 研究使用风疹疫苗株RA27/3作为活病毒载体表达HIV Env糖蛋白,并在恒河猴中评估免疫原性。
主要发现
- 风疹/Env载体可稳定表达来自HIV C亚型426c株、长度达363个氨基酸的Env核心糖蛋白。
- 表达的Env糖蛋白可结合靶向天然CD4结合位点的广谱中和抗体。
- 载体在恒河猴体内生长良好,全部动物产生抗风疹抗体疫苗「take」。
- 单独载体诱导的Env抗体滴度中等,风疹/Env初免后同源蛋白加强产生强应答。
- 多剂接种后中和抗体逐渐出现。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Following HIV infection, most people make antibodies to gp120 and gp41, yet only a few make broadly neutralizing antibodies that target key antigenic sites on the envelope glycoproteins. The induction of broadly neutralizing antibodies by immunization remains a major challenge of HIV vaccine research. Difficulties include: variable protein sequence, epitopes that depend on the native conformation, glycosylation that conceals key antigenic determinants, and the assembly of Env trimers that mimic viral spikes. In addition, more potent immunogens may be needed to initiate the response of germline antibody precursors and drive B cell maturation toward antibodies with broad neutralizing activity. We have expressed HIV Env glycoproteins by incorporation into live attenuated rubella viral vectors. The rubella vaccine strain RA27/3 has demonstrated its safety and potency in millions of children. As a vector, it has elicited potent and durable immune responses in macaques to SIV Gag vaccine inserts. We now find that rubella/env vectors can stably express Env core derived glycoproteins ranging in size up to 363 amino acids from HIV clade C strain 426c. The expressed Env glycoproteins bind broadly neutralizing antibodies that target the native CD4 binding site. The vectors grew well in rhesus macaques, and they elicited a vaccine "take" in all animals, as measured by anti-rubella antibodies. By themselves, the vectors elicited modest antibody titers to the Env insert. But the combination of rubella/env prime followed by a homologous protein boost gave a strong response. Neutralizing antibodies appeared gradually after multiple vaccine doses. The vectors will be useful for testing new vaccine inserts and immunization strategies under optimized conditions of vector growth and protein expression.
引用
- Virnik K, Nesti E, Dail C, et al. Live rubella vectors can express native HIV envelope glycoproteins targeted by broadly neutralizing antibodies and prime the immune response to an envelope protein boost. Vaccine. 2018. PMID: 30037665. doi:10.1016/j.vaccine.2018.07.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。